多数感应抑制剂 (QSI):一个专利审查 (2019-2023)
Chiara Spaggiari1, Clementine Yamukujije1, Marco Pieroni1
1Department of Food and Drugs, University of Parma, Parma, Italy.
Expert opinion on therapeutic patents
|April 12, 2025
概括
质量感应抑制剂 (QSI) 提供了一种针对细菌病原体的新策略,通过阻止毒性而不会促进耐药性. 本综述分析了QSIs最近的专利,突出了它们作为传统抗生素替代品的潜力.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 专利分析 专利分析
背景情况:
- 细菌的集体行为受到量子感应 (QS) 的调节,涉及细胞密度依赖的信号和毒性基因表达.
- 质量感应抑制剂 (QSI) 是破坏质量感应系统的化合物,阻断病原体的毒性机制.
- 质量分析仪在打击抗微生物药物耐药性方面具有前景,为传统抗生素提供了替代品.
研究的目的:
- 对专利和专利申请进行全面的分析,这些专利和专利申请涉及到治疗中使用的群体感知抑制剂.
- 从2019年到2023年,审查QSI研究的进展.
主要方法:
- 在 Espacenet 和 Google 专利数据库中进行系统搜索.
- 纳入标准侧重于专利和有关QSI治疗用途的申请.
- 搜索的时间框架仅限于2019年至2023年.
主要成果:
- 该审查确定并分析了有关QSI的最近专利和专利申请.
- 关键发现突出显示了对基于QSI的治疗方法日益增长的兴趣和发展.
- 专利涵盖了QSI的各种应用和化学类.
结论:
- 昆士兰抗生素代表了传统抗生素的有希望的替代品,因为它们可以减弱毒性,而不会施加选择性压力.
- 专利格局表明,QSI在临床应用方面取得了重大进展.
- 进一步的研究和开发对于将QSI潜力转化为有效的临床治疗至关重要.
相关概念视频
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...